These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 20529669

  • 1. Performance of CEA and CA19-9 in identifying pleural effusions caused by specific malignancies.
    Hackbarth JS, Murata K, Reilly WM, Algeciras-Schimnich A.
    Clin Biochem; 2010 Sep; 43(13-14):1051-5. PubMed ID: 20529669
    [Abstract] [Full Text] [Related]

  • 2. Diagnostic value of CA 72-4, carcinoembryonic antigen, CA 15-3, and CA 19-9 assay in pleural fluid. A study of 207 patients.
    Villena V, López-Encuentra A, Echave-Sustaeta J, Martín-Escribano P, Ortuño-de-Solo B, Estenoz-Alfaro J.
    Cancer; 1996 Aug 15; 78(4):736-40. PubMed ID: 8756365
    [Abstract] [Full Text] [Related]

  • 3. New approaches in the diagnostic procedure of malignant pleural effusions.
    Terracciano D, Di Carlo A, Papa P, Cicalese M, Maietta P, Cecere C, Mariano A, Macchia V.
    Oncol Rep; 2004 Jul 15; 12(1):79-83. PubMed ID: 15201963
    [Abstract] [Full Text] [Related]

  • 4. Clinical utility of a combination of tumour markers in the diagnosis of malignant pleural effusions.
    Gaspar MJ, De Miguel J, García Díaz JD, Díez M.
    Anticancer Res; 2008 Jul 15; 28(5B):2947-52. PubMed ID: 19031938
    [Abstract] [Full Text] [Related]

  • 5. Soluble oncoprotein 185HER-2 in pleural fluid has limited usefulness for the diagnostic evaluation of malignant effusions.
    Porcel JM, Salud A, Vives M, Esquerda A, Rodríguez-Panadero F.
    Clin Biochem; 2005 Nov 15; 38(11):1031-3. PubMed ID: 15925354
    [Abstract] [Full Text] [Related]

  • 6. The diagnostic usefulness of tumour markers CEA and CA-125 in pleural effusion.
    Sthaneshwar P, Yap SF, Jayaram G.
    Malays J Pathol; 2002 Jun 15; 24(1):53-8. PubMed ID: 16329556
    [Abstract] [Full Text] [Related]

  • 7. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
    Porcel JM, Vives M, Esquerda A, Salud A, Pérez B, Rodríguez-Panadero F.
    Chest; 2004 Dec 15; 126(6):1757-63. PubMed ID: 15596670
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic value of three tumor markers determined in pleural effusions.
    Conejo JR, Benedito JE, Jimenez A, Menchen M, Cano J, Granizo V, Larrodera L.
    Eur J Clin Chem Clin Biochem; 1996 Feb 15; 34(2):139-42. PubMed ID: 8833646
    [Abstract] [Full Text] [Related]

  • 9. Clinical evaluation of four tumor markers in malignant and benign pleural effusions.
    Toumbis M, Chondros K, Ferderigos AS, Daganou M, Dema A, Dalamaga A, Kakari S, Stringou E.
    Anticancer Res; 1992 Feb 15; 12(4):1267-70. PubMed ID: 1503419
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic value of tumor markers for lung adenocarcinoma-associated malignant pleural effusion: a validation study and meta-analysis.
    Feng M, Zhu J, Liang L, Zeng N, Wu Y, Wan C, Shen Y, Wen F.
    Int J Clin Oncol; 2017 Apr 15; 22(2):283-290. PubMed ID: 27990560
    [Abstract] [Full Text] [Related]

  • 11. Diagnostic value of CYFRA 21-1, CEA, CA 19-9, CA 15-3, and CA 125 assays in pleural effusions: analysis of 116 cases and review of the literature.
    Shitrit D, Zingerman B, Shitrit AB, Shlomi D, Kramer MR.
    Oncologist; 2005 Aug 15; 10(7):501-7. PubMed ID: 16079317
    [Abstract] [Full Text] [Related]

  • 12. Clinical value of CYFRA21-1, NSE, CA15-3, CA19-9 and CA125 assay in the elderly patients with pleural effusions.
    Li CS, Cheng BC, Ge W, Gao JF.
    Int J Clin Pract; 2007 Mar 15; 61(3):444-8. PubMed ID: 17313612
    [Abstract] [Full Text] [Related]

  • 13. [Diagnostic value of tumor markers in pleural effusions].
    Botte G, Laferrere L, Etchepare S, Dalurzo D, Duhart JE, Adaro FV.
    Medicina (B Aires); 1990 Mar 15; 50(3):213-6. PubMed ID: 2130207
    [Abstract] [Full Text] [Related]

  • 14. [Clinical value of tumor supplied group of factor combined with CEA in diagnosing tuberculosis pleural effusion and malignant pleural effusion].
    Li YP, Hu CP, Yang HZ.
    Hunan Yi Ke Da Xue Xue Bao; 2003 Dec 15; 28(6):608-10. PubMed ID: 15804072
    [Abstract] [Full Text] [Related]

  • 15. Use of cyst fluid CEA, CA19-9, and amylase for evaluation of pancreatic lesions.
    Snozek CL, Mascarenhas RC, O'Kane DJ.
    Clin Biochem; 2009 Oct 15; 42(15):1585-8. PubMed ID: 19576876
    [Abstract] [Full Text] [Related]

  • 16. [Diagnostic value of the tumor markers TPA-M, CYPFRA 21-1 and CEA in pleural effusion. Prospective comparison of thoracoscopic investigations in patients with pleural effusion].
    Riedel U, Schönfeld N, Savaser A, Serk M, Loddenkemper R.
    Pneumologie; 1999 Oct 15; 53(10):471-6. PubMed ID: 10596548
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic performance of CD66c in lung adenocarcinoma-associated malignant pleural effusion: comparison with CEA, CA 19-9, and CYFRA 21-1.
    Son SM, Han HS, An JY, Choe KH, Lee KM, Lee KH, Kim SS, Lee YM, Lee HC, Song HG, Lee OJ.
    Pathology; 2015 Feb 15; 47(2):123-9. PubMed ID: 25551300
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic value of interleukine-6, transforming growth factor-beta 1 and vascular endothelial growth factor in malignant pleural effusions.
    Duysinx BC, Corhay JL, Hubin L, Nguyen D, Henket M, Louis R.
    Respir Med; 2008 Dec 15; 102(12):1708-14. PubMed ID: 18760578
    [Abstract] [Full Text] [Related]

  • 19. [Diagnostic utility of carcinoembryonic antigen, neuron-specific enolase and squamous cell carcinoma antigen in malignant pleural effusion].
    Sánchez de Cos Escuín J, López Parra S, Disdier Vicente C, Martín Vicente MJ, Masa Jiménez JF, Domínguez Retortillo C.
    An Med Interna; 1996 Aug 15; 13(8):369-73. PubMed ID: 8983362
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic utility of pleural fluid and serum markers in differentiation between malignant and non-malignant pleural effusions.
    Korczynski P, Krenke R, Safianowska A, Gorska K, Abou Chaz MB, Maskey-Warzechowska M, Kondracka A, Nasilowski J, Chazan R.
    Eur J Med Res; 2009 Dec 07; 14 Suppl 4(Suppl 4):128-33. PubMed ID: 20156743
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.